세계의 심혈관 중재시술 및 말초혈관 기기 시장 : 제품 유형별, 적응증별, 연령층별, 최종사용자별, 지역별(2025-2033년)

The global interventional cardiology and peripheral vascular devices market size reached USD 26.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.

Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.

Interventional Cardiology and Peripheral Vascular Devices Market Trends:

The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Product Type Insights:

• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Accessories
• Angioplasty Balloons
• Angioplasty Stents
• Angioplasty Catheters
• Endovascular Aneurysm Repair Stent Grafts

Indication Insights:

• Coronary Intervention
• Peripheral Arterial Disease

Age Group Insights:

• Geriatric
• Adults
• Paediatric

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global interventional cardiology and peripheral vascular devices market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global interventional cardiology and peripheral vascular devices market?
• What is the impact of each driver, restraint, and opportunity on the global interventional cardiology and peripheral vascular devices market?
• What are the key regional markets?
• Which countries represent the most attractive interventional cardiology and peripheral vascular devices market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the interventional cardiology and peripheral vascular devices market?
• What is the breakup of the market based on the indication?
• Which is the most attractive indication in the interventional cardiology and peripheral vascular devices market?
• What is the breakup of the market based on the age group?
• Which is the most attractive age group in the interventional cardiology and peripheral vascular devices market?
• What is the breakup of the market based on end user?
• Which is the most attractive end user in the interventional cardiology and peripheral vascular devices market?
• What is the competitive structure of the global interventional cardiology and peripheral vascular devices market?
• Who are the key players/companies in the global interventional cardiology and peripheral vascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Interventional Cardiology and Peripheral Vascular Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Inferior Vena Cava (IVC) Filters
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Plaque Modification Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hemodynamic Flow Alteration Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Accessories
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Angioplasty Balloons
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Angioplasty Stents
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Angioplasty Catheters
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Endovascular Aneurysm Repair Stent Grafts
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast

7 Market Breakup by Indication

• 7.1 Coronary Intervention
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Peripheral Arterial Disease
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Age Group

• 8.1 Geriatric
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Adults
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Paediatric
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

• 11.1 Overview
• 11.2 Drivers
• 11.3 Restraints
• 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 B. Braun Melsungen AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 SWOT Analysis
  • 15.3.3 Becton Dickinson and Company
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Biotronik SE & Co. KG
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 SWOT Analysis
  • 15.3.5 Boston Scientific Corporation
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Cook Group Incorporated
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Cordis Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Koninklijke Philips N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Medtronic plc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Teleflex Incorporated
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Terumo Corporation
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.